Diagnostic Approach for Cervical Lymphadenopathy

Rationale for Skipping CT

CT relies primarily on size criteria and has limited soft-tissue contrast compared to ultrasound for superficial nodes, making ultrasound-guided FNA a more direct approach for tissue diagnosis, as recommended by the American College of Radiology 1
For cervical lymphadenopathy, CT is most useful for evaluating deep mediastinal or retroperitoneal nodes that are inaccessible to ultrasound, not for superficial cervical nodes, according to the European Respiratory Society and the American College of Chest Physicians 2, 3

Imaging alone cannot reliably distinguish benign from malignant lymph nodes, and ultrasound-guided FNA has excellent diagnostic yield and is safe, with the European Society for Medical Oncology noting the importance of tissue diagnosis 6, 2
The National Comprehensive Cancer Network recommends that if FNA confirms malignancy, CT chest/abdomen/pelvis would then be appropriate for staging to evaluate for distant metastases or identify an occult primary tumor, highlighting the role of CT in specific scenarios 4, 3

Direct referral to ENT for ultrasound-guided FNA avoids unnecessary radiation exposure, additional cost, and diagnostic delay, and is an established procedure for lymph node evaluation, as noted by the National Comprehensive Cancer Network 4
The American College of Radiology suggests that CT would only be indicated if there is clinical suspicion of deep extension or involvement of structures not assessable by physical exam and ultrasound, or if the patient has symptoms suggesting systemic disease 1, 7